Rayence Co., Ltd.
Financials
Valuation Metrics
Rayence Co., Ltd.'s Market Cap is ₩1044B. At end of 2025 it was ₩863B. Ranked #1220 of 2,436 in KR market (top 50%), #652 of 1,649 on KOSDAQ (top 40%), #42 of 96 in Health Care Equipment & Services (top 44%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 104.36B KRW | KR#1,220/2,436 Sec#42/96 |
| Revenue | 124.23B KRW | KR#1,274/2,436 Sec#21/96 |
| Net Income | 309.4M KRW | KR#1,483/2,436 Sec#49/96 |
| Total Assets | 271.40B KRW | KR#1,067/2,436 Sec#24/96 |
| Net Assets | 239.94B KRW | KR#829/2,436 Sec#19/96 |
| Employees | 230 | KR#984/2,436 Sec#29/96 |
| Value | ||
| P/E | 337.26x | KR#1,489/2,436 Sec#49/96 |
| P/B | 0.43x | KR#660/2,436 Sec#9/96 |
| PEG | 0.13x | KR#440/2,436 Sec#14/96 |
| P/S | 0.84x | KR#1,270/2,436 Sec#21/96 |
| EV/EBITDA | 42.18x | KR#1,296/2,436 Sec#42/96 |
| FCF Yield | 6.85% | KR#759/2,436 Sec#18/96 |
| Profitability | ||
| ROE | 0.13% | KR#1,482/2,436 Sec#49/96 |
| ROA | 0.11% | KR#1,474/2,436 Sec#48/96 |
| Op. Margin | 1.10% | KR#1,467/2,436 Sec#50/96 |
| Revenue Growth | 34.88% | KR#420/2,436 Sec#16/96 |
| Earnings Growth | 2513.30% | KR#23/2,436 Sec#3/96 |
| Financial Health | ||
| Debt Ratio | 13.11% | KR#21/2,436 Sec#2/96 |
| Total Debt | 860.0M KRW | KR#1,976/2,436 Sec#77/96 |
| FCF | 7.14B KRW | KR#806/2,436 Sec#21/96 |
| Cash | 47.65B KRW | KR#773/2,436 Sec#12/96 |
| Current Ratio | 10.94x | KR#85/2,436 Sec#9/96 |
| Net Debt/EBITDA | -34.28x | KR#15/2,436 Sec#1/96 |
| Dividend | ||
| Div. Yield | 4.99% | KR#300/2,436 Sec#1/96 |
| Div. Growth | 200.00% | KR#43/2,436 Sec#4/96 |
| Performance | ||
| 1Y Return | -2.78% | KR#775/2,436 Sec#20/96 |
| 1M Return | 1.78% | KR#707/2,436 Sec#35/96 |
| From 52W High | -15.23% | KR#110/2,436 Sec#6/96 |
| 1Y MDD | -29.37% | KR#194/2,436 Sec#5/96 |
| Trading | ||
| Volume | 35,139 shares | KR#1,546/2,436 Sec#66/96 |
| Foreign Own. | 2.36% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 23 KRW | KR#1,495/2,436 Sec#49/96 |
| BPS | 15,222 KRW | KR#648/2,436 Sec#10/96 |
Company Info
RAYENCE was established in 2011 following the spin-off of its DR business division, and holds several subsidiaries including OSKO MEX and Woori-en Co., Ltd. The company manufactures and sells digital X-ray detectors for medical, dental, veterinary, and industrial applications, and has developed flexible products using CMOS detector technology. RAYENCE leads the market through X-ray Imaging Solutions, expands into the veterinary medical market via its subsidiaries, and broadens its product lineup with new product launches. It is headquartered in Hwaseong-si, Gyeonggi-do.